Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;42(9):1368-1379.
doi: 10.1016/j.jcrs.2016.06.006.

Cataract surgery and nonsteroidal antiinflammatory drugs

Richard S Hoffman, Rosa Braga-Mele, Kendall Donaldson, Geoffrey Emerick, Bonnie Henderson, Malik Kahook, Nick Mamalis, Kevin M Miller, Tony Realini, Neal H Shorstein, Richard K Stiverson, Barbara Wirostko; ASCRS Cataract Clinical Committee and the American Glaucoma Society
Review

Cataract surgery and nonsteroidal antiinflammatory drugs

Richard S Hoffman et al. J Cataract Refract Surg. 2016 Sep.

Abstract

Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes.

Financial disclosure: Proprietary or commercial disclosures are listed after the references.

PubMed Disclaimer

References

    1. Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Topical ocular delivery of NSAIDs. [Accessed April 27. 2016];AAPS J. 2008 10:229–241. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751374/pdf/12248_2008_Artic.... - PMC - PubMed
    1. Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs. 2007;67:1291–1308. - PubMed
    1. Flach AJ. Topical nonsteroidal anti-inflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42:1–11. - PubMed
    1. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217:89–98. - PubMed
    1. Rojanasakul Y, Robinson JR. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm. 1989;55:237–246.

MeSH terms

Substances